News

Zymenex sells clinical candidate Metazym to Shire for 135 MUSD

Zymenex gets US Orphan Approval

Zymenex gets FDA approval of IND

US Natural History Study of MLD

Zymenex has received a gracious grant from the ATHENA HOPE FOUNDATION..

Zymenex has received a gracious grant from The British Trust for The Myelin Project

Novel Natural History Study to answer question in Rare Disease

Phase II trial for Zymenex lethal disease treatment candidate

Zymenex in Phase I/II clinical trial in seriously ill children with MLD

Zymenex has recieved a gracious grant from the MLD Foundation (USA)